Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-HBE positive chronic hepatitis B patients: a controlled pilot study

2001 ◽  
Vol 34 (0) ◽  
pp. 134
Author(s):  
T Santantonio
Keyword(s):  
Chronic Hepatitis ◽  
Pilot Study ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Positive Chronic Hepatitis

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

2002 ◽  
Vol 36 (6) ◽  
pp. 799-804 ◽  
Author(s):  
Teresa Santantonio ◽  
Grazia Anna Niro ◽  
Emanuele Sinisi ◽  
Gioacchino Leandro ◽  
Maria Insalata ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Pilot Study ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Positive Chronic Hepatitis

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

2003 ◽  
Vol 38 (6) ◽  
pp. 818-826 ◽  
Author(s):  
Eugene R Schiff ◽  
Jules L Dienstag ◽  
Selim Karayalcin ◽  
Ian S Grimm ◽  
Robert P Perrillo ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Hepatitis B E Antigen ◽  
Positive Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document